Search





Search





Markets
/
Stocks
/
drug
/

Bright Minds Biosciences Inc

DRUG

Add to Watchlist

73.260USD

-1.370-1.84%

Close 07-31 16:00（ET）Quotes delayed by 15 min

721.85MMarket Cap

LossP/E TTM

Bright Minds Biosciences Inc

73.260

-1.370-1.84%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

DRUG Cash Flow Statement

You can access the annual and quarterly cash flow statements of Bright Minds Biosciences Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-177.39%-6.73M

-186.02%-4.27M

-100.03%-926.50K

-1156.02%-2.54M

-201.24%-2.43M

-81.78%-1.49M

61.32%-463.17K

114.55%240.16K

46.77%-805.09K

69.14%-822.09K

43.74%-1.20M

42.33%-1.65M

58.51%-1.51M

46.20%-2.66M

10.92%-2.13M

3.72%-2.86M

-159.01%-3.65M

-800.97%-4.95M

---2.39M

---2.97M

---1.41M

-819.96%-549.52K

---59.73K

Net income from continuing operations

-157.94%-7.61M

-11307.16%-5.56M

-285.97%-2.99M

-1750.63%-3.79M

-413.88%-2.95M

102.95%49.61K

49.38%-773.44K

115.77%229.90K

72.00%-574.14K

27.88%-1.68M

48.40%-1.53M

45.14%-1.46M

54.31%-2.05M

51.93%-2.34M

-3.28%-2.96M

24.77%-2.66M

-183.43%-4.49M

-628.28%-4.86M

---2.87M

---3.53M

---1.58M

-2023.57%-667.06K

---31.41K

Operating gains losses

-35.91%14.41K

-32.46%14.54K

-34.65%12.43K

-36.68%11.47K

24.12%22.48K

18.88%21.53K

5.01%19.02K

0.00%18.11K

-0.01%18.11K

0.01%18.11K

125.36%18.11K

--18.11K

--8.04K

----

Other non-cash items

-8917.23%-1.04M

164.67%1.05M

2697.65%389.15K

1512.29%559.34K

443.28%11.76K

-3953.47%-1.63M

-109.17%-14.98K

69.64%-39.60K

-59.39%2.17K

500.01%42.30K

307.65%163.44K

-3150.50%-130.47K

-23.72%5.33K

103.68%7.05K

48.32%-78.71K

-98.54%4.28K

161.84%6.99K

-1367.44%-191.38K

---152.29K

--293.25K

---11.30K

--15.10K

----

Change in working capital

839.31%1.02M

-517.61%-732.25K

832.37%870.72K

-79.01%-274.67K

71.12%-138.63K

-120.45%-118.56K

136.57%93.39K

52.35%-153.43K

-200.16%-479.99K

168.74%579.85K

-130.26%-255.36K

35.77%-322.00K

-11.94%479.25K

-419.24%-843.60K

233.34%843.75K

-7621.08%-501.36K

779.54%544.20K

-943.21%-162.47K

--253.12K

--6.67K

--61.87K

45.01%-15.57K

---28.32K

-Change in receivables

-204.18%-506.60K

-33.73%-22.46K

-211.06%-102.61K

-105.28%-28.28K

67.23%-166.55K

-108.43%-16.80K

-149.46%-32.99K

862.32%536.01K

-2061.29%-508.21K

-108.35%-8.06K

173.02%66.69K

-162.80%-70.31K

197.00%25.91K

344.04%96.50K

-184.01%-91.34K

371.52%111.97K

26.30%-26.71K

-7808.80%-39.54K

---32.16K

---41.24K

---36.25K

---500.00

----

-Change in prepaid expenses

-110.00%-301.22K

-5.01%-43.39K

-29.01%-204.24K

-416.72%-222.21K

-955.94%-143.44K

-843.64%-41.32K

-238.82%-158.31K

-215.89%-43.00K

181.02%16.76K

-169.82%-4.38K

235.54%114.04K

662.24%37.11K

-136.29%-20.68K

-75.93%6.27K

-109.65%-84.14K

-96.10%4.87K

129.50%57.00K

39.23%26.05K

---40.13K

--124.73K

---193.23K

--18.71K

--0.00

-Change in payables and accrued expense

969.52%1.83M

-1002.54%-666.40K

313.64%1.18M

96.26%-24.18K

1395.54%171.36K

-110.20%-60.44K

165.28%284.69K

-123.84%-646.44K

-97.58%11.46K

162.58%592.29K

-142.79%-436.10K

53.28%-288.80K

-7.76%474.02K

-535.25%-946.38K

213.21%1.02M

-704.66%-618.19K

76.39%513.92K

-340.96%-148.98K

--325.41K

---76.83K

--291.35K

-19.29%-33.78K

---28.32K

Cash from non-recurring investing activities

Cash from operating activities

-177.39%-6.73M

-186.02%-4.27M

-100.03%-926.50K

-1156.02%-2.54M

-201.24%-2.43M

-81.78%-1.49M

61.32%-463.17K

114.55%240.16K

46.77%-805.09K

69.14%-822.09K

43.74%-1.20M

42.33%-1.65M

58.51%-1.51M

46.20%-2.66M

10.92%-2.13M

3.72%-2.86M

-159.01%-3.65M

-800.97%-4.95M

---2.39M

---2.97M

---1.41M

-819.96%-549.52K

---59.73K

Investing cash flow

Cash from non-current investing activities

Net cash flow from investing activities

----

100.00%0.00

----

--22.88K

---22.88K

----

Financing cash flow

Cash flow from continuous financing activities

73654.52%166.23M

-81.09%9.84M

103443.55%24.34M

44.39%-12.21K

1126.47%225.38K

5826.92%52.04M

-8.83%-23.56K

-2.18%-21.96K

-2.17%-21.96K

-61.05%878.04K

-100.43%-21.64K

-279.07%-21.49K

-1376.13%-21.49K

1806.39%2.25M

52308.82%5.06M

102.20%12.00K

-99.99%1.68K

-93.76%118.25K

---9.70K

---545.55K

--24.71M

--1.90M

--0.00

Net cash flow from debt Issuance/repayment

22.40%-19.11K

19.60%-19.13K

20.04%-19.08K

15.55%-18.54K

-12.17%-24.63K

-8.35%-23.79K

-10.23%-23.86K

-2.18%-21.96K

-2.17%-21.96K

-2.18%-21.96K

-202.22%-21.64K

---21.49K

---7.16K

----

Net cash flow from common stock issuance/repurchase

--176.99M

-78.93%10.25M

--24.45M

--0.00

5303.22%48.63M

--0.00

-26.08%900.00K

-100.00%0.00

--0.00

--1.22M

--4.03M

100.00%0.00

-100.00%0.00

--0.00

---39.25K

--25.91M

--1.87M

--0.00

Proceeds from stock option exercised by employees

-87.61%30.99K

-99.31%6.43K

--111.06K

--6.33K

--250.01K

--930.09K

----

Proceeds from issuance of warrants

--0.00

-100.00%0.00

-99.76%0.73

--0.00

--2.59M

--302.00

----

-100.00%0.00

--0.00

817.78%1.09M

--1.84M

-86.27%12.00K

-100.00%0.00

--118.25K

--0.00

--87.40K

--10.00K

----

Net cash flow from other financing activities

---10.77M

-370.62%-394.00K

---201.97K

--0.00

---83.72K

--0.00

----

100.00%0.00

--0.00

-100.00%0.00

---26.98K

-8164.57%-801.66K

100.00%0.00

100.14%1.68K

-100.00%0.00

---9.70K

---593.70K

---1.21M

--22.88K

----

Net cash from non-recurrent financing activities

Net cash from financing activities

73654.52%166.23M

-81.09%9.84M

103443.55%24.34M

44.39%-12.21K

1126.47%225.38K

5826.92%52.04M

-8.83%-23.56K

-2.18%-21.96K

-2.17%-21.96K

-61.05%878.04K

-100.43%-21.64K

-279.07%-21.49K

-1376.13%-21.49K

1806.39%2.25M

52308.82%5.06M

102.20%12.00K

-99.99%1.68K

-93.76%118.25K

---9.70K

---545.55K

--24.71M

--1.90M

--0.00

Net cash flow

Beginning cash balance

11.91%64.79M

965.21%60.93M

506.56%37.55M

579.33%40.30M

756.25%57.90M

-15.23%5.72M

-23.86%6.19M

-38.66%5.93M

-39.69%6.76M

-41.97%6.75M

-5.90%8.13M

-15.66%9.67M

-25.84%11.21M

-41.15%11.63M

-60.74%8.64M

-54.94%11.47M

616.87%15.12M

2370.22%19.76M

--22.01M

--25.45M

--2.11M

900.02%799.93K

--79.99K

Current period cash flow changes

7342.07%160.54M

-91.35%4.51M

4998.75%23.03M

-1305.08%-3.11M

-167.33%-2.22M

381838.17%52.18M

66.00%-470.15K

116.72%257.81K

46.13%-829.21K

103.28%13.66K

-146.29%-1.38M

45.47%-1.54M

57.84%-1.54M

91.03%-416.41K

232.94%2.99M

17.89%-2.83M

-115.64%-3.65M

-454.56%-4.64M

---2.25M

---3.44M

--23.34M

2291.50%1.31M

---59.73K

Effect of exchange rate changes

6246.14%1.04M

-164.73%-1.06M

-2432.14%-386.55K

-1510.04%-558.45K

-678.29%-16.85K

3954.03%1.63M

110.14%16.57K

-69.64%39.60K

59.39%-2.17K

-500.01%-42.30K

-417.62%-163.44K

467.93%130.47K

23.72%-5.33K

-103.68%-7.05K

-66.21%51.46K

-69.49%22.97K

-161.84%-6.99K

1367.44%191.38K

--152.29K

--75.30K

--11.30K

---15.10K

----

Ending cash balance

304.69%225.33M

13.03%65.44M

959.06%60.58M

500.85%37.19M

838.57%55.68M

756.25%57.90M

-15.23%5.72M

-23.86%6.19M

-38.66%5.93M

-39.69%6.76M

-41.97%6.75M

-5.90%8.13M

-15.66%9.67M

-25.84%11.21M

-41.15%11.63M

-60.74%8.64M

-54.94%11.47M

616.87%15.12M

--19.76M

--22.01M

--25.45M

10310.60%2.11M

--20.26K

Free cash flow

----

-800.97%-4.95M

----

---1.41M

---549.52K

----

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Bright Minds Biosciences Inc Generate?



Bright Minds Biosciences Inc generated -6.35M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Bright Minds Biosciences Inc's Operating Cash Flow Change Year Over Year?



Bright Minds Biosciences Inc's operating cash flow increased by -392.66% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Bright Minds Biosciences Inc's Financing Cash Flow Changed?



Bright Minds Biosciences Inc used 62.52M in financing activities in the latest quarter.

What is free cash flow and why does it matter for DRUG?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.